SEAGULL HEALTH
Your health,We care!
Tislelizumab Injection, with its significant efficacy and favorable tolerance, provides diverse treatment options and long-term survival hope for a large number of patients with advanced tumors.
AuthenticGuaranteeFast DeliveryPrivacy Tislelizumab (anti-PD-1 monoclonal antibody) should be individualized for patients in special populations, with key considerations for pregnant women,···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 75
Patients treated with tislelizumab injection should focus on adverse reaction monitoring, infection prevention and management of special populations, ···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 73
As an immunotherapeutic agent (PD-1 inhibitor), the main side effects of tislelizumab stem from an overactivated immune system attacking normal body t···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 78
The recommended standard dosage of Tislelizumab for adults is 200 mg administered via intravenous infusion, once every 3 weeks.The specific dosage sha···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 76
Tislelizumab is an antineoplastic biological agent, with the active ingredient being a humanized recombinant anti-PD-1 monoclonal antibody. It mainly ···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 77
Tislelizumab (a PD-1 inhibitor) is contraindicated mainly in patients with hypersensitivity to the drug components, active autoimmune diseases, uncont···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 79
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
